Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Contraception|May 22, 2002
Recent advances in hormonal male contraceptionM C Meriggiola, A Costantino, S Cerpolini
International Journal of Andrology|October 1, 1995
Testosterone enanthate at a dose of 200 mg/week decreases HDL-cholesterol levels in healthy menM C Meriggiola, S Marcovina, C A Paulsen, et al.
European Journal of Endocrinology|February 13, 2010
Endocrine treatment of transsexual persons: an Endocrine Society Clinical Practice Guideline: commentary from a European perspectiveM C Meriggiola, E A Jannini, A Lenzi, et al.
Human Reproduction (Oxford, England)|February 1, 1996
Annual patterns of luteinizing hormone, follicle stimulating hormone, testosterone and inhibin in normal menM C Meriggiola, E A Noonan, C A Paulsen, et al.
Human Reproduction (Oxford, England)|July 1, 1998
Low dose of cyproterone acetate and testosterone enanthate for contraception in menM C Meriggiola, W J Bremner, A Costantino, et al.
Fertility and Sterility|December 9, 1997
An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in menM C Meriggiola, W J Bremner, A Costantino, et al.
Minerva Ginecologica|June 20, 2007
Current status and future perspectives in male contraceptionA Costantino, S Cerpolini, A M Perrone, et al.
American Journal of Obstetrics and Gynecology|November 1, 1990
Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogsM Filicori, C Flamigni, E Campaniello, et al.
Pageof 3